536 imaging of striatal pre- and postsynaptic dopaminergic status in rest- less legs syndrome with periodic leg movements in sleep. J Neurol 2002; 249: 164-70. 7. Allen RP, Earley CJ. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 2001; 18: 128-47. 8. Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J. CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res 2005; 14: 43-7. 9. Brodeur C, Montplaisir J, Godbout R, Marinier R. Treatment of restless legs syndrome and periodic movements during sleep with L- dopa: a double-blind, controlled study. Neurology 1988; 38: 1845-8. 10. DeLong MR. Primate models of movement disorders of basal gan- glia origin. Trends Neurosci 1990; 13: 281-5. Y.-K. Shin, S.-C. Hong, Y.K. Ihn, et al. 11. Loescher W, Hoenack D, Taylor CP. Gabapentin increases aminooxy- acetic acid-induced GABA accumulation in several regions of rat brain. Neurosci Lett 1991; 128: 150-4. 12. Agid Y, Bonnet AM, Ruberg M, Javoy-Agid F. Pathophysiology of L-dopa-induced abnormal involuntary movements. Psychopharma- cology 1985; 2 (Suppl): 145-59. 13. Rao ML. Gabapentin augments whole blood serotonin in healthy young men. J Neural Trans 1988; 73: 129-34. 14. Walters AS. Review of receptor agonist and antagonist studies rele- vant to the opiate system in restless legs syndrome. Sleep Med 2002; 3: 301-4. 15. Lauerma H, Markkula J. Treatment of restless legs syndrome with tramadol: an open study. J Clin Psychiatry 1999; 60: 241-4.